ABHD17AP4: A Potential Drug Target and Biomarker (G729495)
ABHD17AP4: A Potential Drug Target and Biomarker
Introduction
ABHD17AP4 is a gene that encodes a protein known as FAM108A5P. The protein is a member of the ABH domain family, which is a family of proteins that are involved in various cellular processes, including cell adhesion, migration, and invasion. ABHD17AP4 is unique because it has been shown to be highly expressed in human tissues and has been implicated in the development and progression of various diseases, including cancer.
The search for new drug targets and biomarkers is an ongoing process in the pharmaceutical industry. Drug targets are proteins that are involved in the development and progression of diseases and are targeted by drugs to inhibit their activity. Biomarkers are proteins that are derived from cells or tissues and can be used to diagnose, monitor, or predict the progression of a disease.
ABHD17AP4 is a potential drug target because it has been shown to be involved in the development and progression of various diseases, including cancer. It is also a good candidate for biomarker because it is highly expressed in human tissues and has been shown to be involved in the development and progression of diseases.
The Protein encoded by ABHD17AP4
ABHD17AP4 is a member of the ABH domain family, which is a family of proteins that are involved in various cellular processes, including cell adhesion, migration, and invasion. The ABH domain is characterized by the presence of a unique calbindin-like repeat ( CLRS) in the cytoplasm of the cell. The CLRS is a characteristic of the ABH domain proteins that allows them to interact with various signaling molecules, including Wnt, FGF, and PDGF.
The ABHD17AP4 protein is 174 amino acids long and has a molecular weight of 21 kDa. It has a unique structure that is characterized by the presence of a N-terminal alpha-helix, a unique G-cellular bar
Protein Name: ABHD17A Pseudogene 4
More Common Targets
ABHD17AP5 | ABHD17AP6 | ABHD17B | ABHD17C | ABHD18 | ABHD2 | ABHD3 | ABHD4 | ABHD5 | ABHD6 | ABHD8 | ABI1 | ABI2 | ABI3 | ABI3BP | ABITRAM | ABL1 | ABL2 | ABLIM1 | ABLIM2 | ABLIM3 | ABO | ABR | ABRA | ABRACL | ABRAXAS1 | ABRAXAS2 | ABT1 | ABTB1 | ABTB2 | ABTB3 | ACAA1 | ACAA2 | ACACA | ACACB | ACAD10 | ACAD11 | ACAD8 | ACAD9 | ACADL | ACADM | ACADS | ACADSB | ACADVL | ACAN | ACAP1 | ACAP2 | ACAP3 | ACAT1 | ACAT2 | ACBD3 | ACBD4 | ACBD5 | ACBD6 | ACBD7 | ACCS | ACCSL | ACD | ACE | ACE2 | ACE2-DT | ACE3P | ACER1 | ACER2 | ACER3 | Acetyl-CoA Carboxylases (ACC) | Acetylcholine Receptors (Nicotinic) (nAChR) | ACHE | Acid-Sensing Ion Channel (ASIC) | ACIN1 | ACKR1 | ACKR2 | ACKR3 | ACKR4 | ACKR4P1 | ACLY | ACMSD | ACO1 | ACO2 | ACOD1 | ACOT1 | ACOT11 | ACOT12 | ACOT13 | ACOT2 | ACOT4 | ACOT6 | ACOT7 | ACOT8 | ACOT9 | ACOX1 | ACOX2 | ACOX3 | ACOXL | ACOXL-AS1 | ACP1 | ACP2 | ACP3 | ACP4 | ACP5